secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0000950170-24-053917
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix Medical Q1 GAAP EPS $0.05 vs $0.17 YoY; revenue up slightly to $495M
------------------------------------------------------------------------------

- Net revenue $495M vs $491M YoY; same-unit revenue up 2.3%.
- Net income $4M down from $14.2M; GAAP EPS $0.05 vs $0.17.
- Adjusted EPS $0.20 vs $0.23; Adjusted EBITDA $37M vs $40.1M.
- FY 2024 Adjusted EBITDA guidance reaffirmed $200M-$220M.
- Cash used in ops $122.6M; total debt $705M at quarter end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017024053917/0000950170-24-053917-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017024053917/md-20240507.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-053917

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer